Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical develops innovative resuscitation technologies for emergency and critical care.

view more →

AtaCor Medical is developing next-generation cardiac rhythm management systems

view more →

Avivomed is a Minneapolis-based medical device company developing next-generation neuromodulation therapies

view more →

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technologies to treat autoimmune diseases

view more →

Cardiosense combines multimodal wearable sensors with AI to noninvasively detect early signs of cardiac disease and guide personalized therapy.

view more →

Contego Medical develops integrated medical devices for revascularization procedures

view more →

CVRx develops an implantable system that delivers baroreflex activation therapy. IPO in June 2021 (NASDAQ: CVRX).

view more →

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

view more →

Developer of a system to enhance embolic cerebral protection. Acquired by Edwards Lifesciences (NYSE: EW) in March 2011.

view more →

Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes.

view more →

Entegrion develops point-of-care hemostasis solutions centered on its Viscoelastic Coagulation Monitor (VCM)

view more →

GoCheck Kids provides a smartphone-based pediatric vision and hearing screening platform

view more →

HistoSonics, Inc. is pioneering a novel, non-invasive therapeutic platform based on histotripsy. Acquired by Bezos Expeditions, Wellington K5 Global 2025

view more →

iVEAcare is developing next-generation neuromodulation therapies using advanced implantable devices and software

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

RapidPulse is a medical device company developing an innovative, minimally invasive vascular system for treating acute ischemic stroke.

view more →

Standard Bariatrics is a medical device company focused on advancing bariatric surgery.

view more →

Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain

view more →

Wesper is a digital health company developing an FDA-cleared, at-home sleep testing platform that delivers clinical-grade diagnostics for sleep disorders

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910